M05.79

Clinical Causes: The exact cause of rheumatoid arthritis remains uncertain, but it involves a combination of genetic, environmental, and immune system factors. The immune system mistakenly attacks the body's synovial tissues, leading to inflammation. Known or suspected factors contributing to RA include: - Genetic predispositions, such as specific gene variants - Environmental triggers like smoking, infections, or exposure to certain chemicals - Hormonal influences, especially in women - Abnormal immune system responses In cases classified under M05.79, this immune-mediated process predominantly targets multiple joints, with no identified systemic organ involvement.

Key Symptoms: Rheumatoid arthritis with multiple joint involvement often presents with a variety of symptoms that can affect daily activities and quality of life. Typical signs include: - Persistent joint pain and tenderness - Swelling in several joints, often symmetrical, such as wrists, fingers, knees, and ankles - Reduced joint mobility and stiffness, especially in the morning or after periods of inactivity - Warmth and redness around affected joints - Fatigue and general feeling of being unwell - Possible development of deformities over time if untreated Since this form does not involve internal organs, systemic symptoms like lung or heart issues are usually absent.

Diagnosis Path: Diagnosing rheumatoid arthritis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Healthcare providers typically look for signs and symptoms alongside specific laboratory markers: - Blood tests for rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies - Elevated inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) - X-rays or ultrasounds to assess joint damage or inflammation - Exclusion of other conditions that can mimic RA, like gout or osteoarthritis In cases of M05.79, confirmation involves identifying multiple sites affected by joint inflammation with positive RF, without evidence of systemic organ involvement.

Treatment Protocols: Managing rheumatoid arthritis with rheumatoid factor targeting multiple joints without systemic involvement typically involves a multidisciplinary approach aimed at reducing inflammation, preventing joint damage, and maintaining functional ability. Common strategies include: - Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate to slow disease progression - Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and inflammation - Corticosteroids for short-term control of severe symptoms - Physical therapy and occupational therapy to improve joint function and strength - Regular monitoring and imaging to track disease activity While medication is central to treatment, lifestyle modifications like maintaining a healthy weight, engaging in low-impact exercises, and avoiding joint stress are also recommended.